Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 1:12:1325419.
doi: 10.3389/fped.2024.1325419. eCollection 2024.

Endoscopic variceal ligation combined with sclerotherapy for management of gastroesophageal variceal bleeding in pediatric patients: a single-center retrospective study

Affiliations

Endoscopic variceal ligation combined with sclerotherapy for management of gastroesophageal variceal bleeding in pediatric patients: a single-center retrospective study

Ming-Ming Li et al. Front Pediatr. .

Abstract

Objectives: Portal hypertension (PH) frequently gives rise to severe and life-threatening complications, including hemorrhage accompanied by the rupture of esophageal and gastric varices. In contrast to the guidelines for the management of PH in adults, the optimal endoscopic management of variceal bleeding for secondary prophylaxis in children remains unclear. The present study evaluated the efficacy and safety of endoscopic variceal ligation (EVL) and endoscopic sclerotherapy (EST) to control gastroesophageal variceal bleeding in children.

Methods: This retrospective study included children with gastroesophageal variceal bleeding who underwent EST or EVL at Xinhua Hospital, Shanghai Jiaotong University School of Medicine, between February 2013 and March 2020. Short-term hemostasis rate and long-term rebleeding rate were evaluated. Adverse events related to the procedures, such as esophageal ulcer, esophageal stricture, abnormal embolization, pneumonia and perforation, were also recorded.

Results: EVL (n = 8) and EST (n = 13) were performed successfully in all pediatric patients diagnosed with moderate to severe esophageal varices concurrent with gastric varices. Hemostasis was achieved during episodes of upper gastrointestinal bleeding. The mean volume of each single aliquot of cyanoacrylate injected was 0.3 ± 0.1 ml (range: 0.1-0.5 ml). Varices were eradicated in six (75%) of the eight patients who underwent EVL after a median 2 (range: 1-4) procedures and a median time of 3.40 months (range: 1.10-13.33 months). Eleven (52.4%) of the 21 patients developed rebleeding events, with the mean duration of hemostasis being 11.1 ± 11.6 months (range 1.0-39.2 months). No treatment-related complications, for example, distal embolism, occurred except for abdominal pain in one patient (4.8%).

Conclusions: EST, alone or in combination with EVL, is an effective and safe method of managing gastroesophageal variceal hemorrhage in children undergoing secondary prophylaxis.

Keywords: endoscopic ligation; endoscopic sclerotherapy; gastroesophageal variceal bleeding; portal hypertension; secondary prophylaxis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The procedure of EST treatment. (1) Gastric varices were located at the fundus of gastric. (2) The transparent teflon injector was injected into the varices and blood could be seen. (3) A tissue adhesive agent between two injections of sclerosing agent was injected into the varices. (4) The procedure was successfully conducted.
Figure 2
Figure 2
The procedure of EVL treatment. (1,2) The esophageal varices have a serpentine tortuous uplift with a red sign. (3) The variceal cord was ligated using two bands. (4) The surveillance endoscopy showed the white scars after 3 months.
Figure 3
Figure 3
Active gastric variceal bleeding. (1) Varices have a serpentine tortuous uplift with a red sign. (2,3) Visible bleeding or clotted blood over a esophagogastric varix.

References

    1. Ling SC, Walters T, McKiernan PJ, Schwarz KB, Garcia-Tsao G, Shneider BL. Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr. (2011) 52(3):254–61. 10.1097/MPG.0b013e318205993a - DOI - PMC - PubMed
    1. Maksoud-Filho JG, Gonçalves ME, Cardoso SR, Gibelli NE, Tannuri U. Long-term follow-up of children with extrahepatic portal vein obstruction: impact of an endoscopic sclerotherapy program on bleeding episodes, hepatic function, hypersplenism, and mortality. J Pediatr Surg. (2009) 44(10):1877–83. 10.1016/j.jpedsurg.2009.02.074 - DOI - PubMed
    1. Shneider BL, de Ville de Goyet J, Leung DH, Srivastava A, Ling SC, Duché M, et al. Primary prophylaxis of variceal bleeding in children and the role of MesoRex bypass: summary of the Baveno VI pediatric satellite symposium. Hepatology. (2016) 63(4):1368–80. 10.1002/hep.28153 - DOI - PubMed
    1. Bandika VL, Goddard EA, De Lacey RD, Brown RA. Endoscopic injection sclerotherapy for bleeding varices in children with intrahepatic and extrahepatic portal venous obstruction: benefit of injection tract embolisation. S Afr Med J. (2012) 102(11 Pt 2):884–7. 10.7196/samj.6263 - DOI - PubMed
    1. Zargar SA, Javid G, Khan BA, Yattoo GN, Shah AH, Gulzar GM, et al. Endoscopic ligation compared with sclerotherapy for bleeding esophageal varices in children with extrahepatic portal venous obstruction. Hepatology. (2002) 36(3):666–72. 10.1053/jhep.2002.35278 - DOI - PubMed

LinkOut - more resources